LINDSAY FARWICK: Open Payments
NPI 1346656584 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 37 payments from 18 companies in 2025. Trend: 2023 $1,078 · 2024 $836 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $93 |
| GENZYME CORPORATION | 3 | $93 |
| Pulmonx Corporation | 3 | $64 |
| Baxter Healthcare | 3 | $60 |
| Lilly USA, LLC | 3 | $60 |
| QOL Medical, LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| United Therapeutics Corporation | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: DUPIXENT, TREMFYA, CHARTIS CATHETER, Hillrom - Vest System Model 105 Home Care, Sucraid, Tyvaso, OPSUMIT, ZEPBOUND.
Industry payments across AZ — which companies pay providers there.
